DEGs between the NRGs-activated subgroup and NRGs-suppressed subgroup were mainly enriched in tumor-related signaling pathways including JAK-STAT signaling pathway and PI3K-Akt signaling pathway, transcriptional misregulation and proteoglycans in cancer. This evidence concerns the gene AKT1 and neoplasm.